No image published for this recall

No image published for this recall

JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)

Official notice

31 May 2024

Last checked

31 May 2024

Risk not stated by sourceHealth Canada

An official Health Canada notice concerns JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025). JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk Published 2024-05-31.

What to do now

Return your JAMP Digoxin 0. 0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy. Contact a health care professional immediately if you or someone you are caring for experience serious side effects. Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma. Com, if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada. Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0. 0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada.

Recall number

75604

Official notice

2024-05-31

The hazard

JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

recalled

Recall Numbers

75604

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Jamp Digoxin 0.0625 MG Tablets.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

App estimate

unspecified

Recall details

Recall number

75604

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 31 May 2024. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.